Bloodstram Infections in ICU. Single Centre Observational Study.

Bloodstram Infections in Intensive Care Unit. A Single Centre Bacteriological Analysis Between 2007-2019.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04926935

Enrollment

3502

Registered

2021-06-15

Start date

2007-01-01

Completion date

2019-12-31

Last updated

2021-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antibiotic Resistant Strain, Bloodstream Infection, Intensive Care Unit

Brief summary

Hospital-acquired bloodstream infection (BSI) is serious care problem worldwide associated with significant morbidity and mortality. However, only few nationwide studies have focused on the incidence of BSI, and its results were often inconsistent. The objective of this study was to analyze bloodstream infections in patients hospitalized in the intensive care unit of the tertiary, university hospital. Special attention was put on the etiology of the infections, the antimicrobial susceptibility/resistance of the isolated pathogens, as well as the incidence of central vein catheters infections in the analyzed population. Data were collected in the intensive care unit of the Military Institute of Medicine, Warsaw, Poland, between January, 1, 2007 and December, 31, 2019.

Interventions

DIAGNOSTIC_TESTMicrobiological analysis of blood samples.

Microbiological analysis of blood samples collected from the patients with clinically suspected infection.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* all patients hospitalized in the ICU with clinically suspected infection.

Exclusion criteria

* none.

Design outcomes

Primary

Measure	Time frame	Description
Results of microbiological analysis.	After completion of the microbiological analysis, up to 72 hours.	Results of the microbiological analysis of the blood samples collected from patients with clinically suspected infections hospitalized in the ICU during the study period.
Isolated pathogens' susceptibility for antimicrobial agents. .	After completion of the microbiological analysis, up to 72 hours.	Results of the microbiological analysis of the blood samples collected from patients with clinically suspected infections hospitalized in the ICU during the study period.
Isolated pathogens' resistance for antimicrobial agents. .	After completion of the microbiological analysis, up to 72 hours.	Results of the microbiological analysis of the blood samples collected from patients with clinically suspected infections hospitalized in the ICU during the study period.

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026